Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast CancerLuca Gianni, Gianni Bonadonna, W. Eiermann et al.|Journal of Clinical Oncology|2009Cited by 216
Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative TherapyLuca Gianni, Antonio Llombart‐Cussac, Milvia Zambetti et al.|Clinical Cancer Research|2005Cited by 165